These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 34169435)

  • 1. Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.
    Frenette CT; Levy C; Saab S
    Dig Dis Sci; 2022 Jun; 67(6):1994-2004. PubMed ID: 34169435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi-centre cohort.
    Bajaj JS; O'Leary JG; Tandon P; Wong F; Kamath PS; Biggins SW; Garcia-Tsao G; Lai J; Fallon MB; Thuluvath PJ; Vargas HE; Maliakkal B; Subramanian RM; Thacker LR; Reddy KR
    Aliment Pharmacol Ther; 2019 Jun; 49(12):1518-1527. PubMed ID: 31032966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of Access to Rifaximin Upon Hospital Discharge Is Frequent and Results in Increased Hospitalizations for Hepatic Encephalopathy.
    Stoll AM; Guido M; Pence A; Gentene AJ
    Ann Pharmacother; 2023 Feb; 57(2):133-140. PubMed ID: 35658580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overt Hepatic Encephalopathy: Current Pharmacologic Treatments and Improving Clinical Outcomes.
    Rahimi RS; Brown KA; Flamm SL; Brown RS
    Am J Med; 2021 Nov; 134(11):1330-1338. PubMed ID: 34242619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of rifaximin versus lactulose for reducing the recurrence of overt hepatic encephalopathy and hopitalizations in cirrhosis.
    Irimia R; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1021-7. PubMed ID: 23700882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic Encephalopathy.
    Flamm SL
    Am J Med Sci; 2018 Sep; 356(3):296-303. PubMed ID: 30286824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on management of patients with overt hepatic encephalopathy.
    Chacko KR; Sigal SH
    Hosp Pract (1995); 2013 Aug; 41(3):48-59. PubMed ID: 23948621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Rifaximin Treatment in Patients with Hepatic Encephalopathy.
    Jesudian AB; Ahmad M; Bozkaya D; Migliaccio-Walle K
    J Manag Care Spec Pharm; 2020 Jun; 26(6):750-757. PubMed ID: 32463782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes of Oral Zinc Therapy in Hepatic Encephalopathy Treatment.
    Fritz MK; Mangino AA; Hunt TV; Pitcock CT; Dugan AJ; Karri K; Yarra P
    Ann Pharmacother; 2023 Aug; 57(8):899-906. PubMed ID: 36367093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrence.
    Sanyal AJ; Kowdley KV; Reau NS; Pyrsopoulos NT; Allen C; Heimanson Z; Bajaj JS
    Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38727685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of rifaximin use following an initial overt hepatic encephalopathy hospitalization on rehospitalization and costs.
    Jesudian AB; Gagnon-Sanschagrin P; Heimanson Z; Bungay R; Chen J; Guérin A; Bumpass B; Borroto D; Joseph G; Dashputre AA
    J Med Econ; 2023; 26(1):1169-1177. PubMed ID: 37664993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Electronic Decision Support Intervention Reduces Readmissions for Patients With Cirrhosis.
    Louissaint J; Grzyb K; Bashaw L; Mohammad RA; Parikh ND; Tapper EB
    Am J Gastroenterol; 2022 Mar; 117(3):491-494. PubMed ID: 35020619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy.
    Hayakawa Y; Tamaki N; Nakanishi H; Kurosaki M; Tanaka Y; Inada K; Ishido S; Kirino S; Yamashita K; Nobusawa T; Matsumoto H; Kakegawa T; Higuchi M; Takaura K; Tanaka S; Maeyashiki C; Kaneko S; Yasui Y; Takahashi Y; Tsuchiya K; Okamoto R; Izumi N
    Intern Med; 2023 Apr; 62(7):973-978. PubMed ID: 36070941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States.
    Volk ML; Burne R; Guérin A; Shi S; Joseph GJ; Heimanson Z; Ahmad M
    J Med Econ; 2021; 24(1):202-211. PubMed ID: 33464935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance of the ICD-10 Code K76.82 for Hepatic Encephalopathy in Patients With Cirrhosis.
    Ozturk NB; Jamil LH; Tapper EB
    Am J Gastroenterol; 2024 Feb; 119(2):364-366. PubMed ID: 37830544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence.
    Hudson M; Schuchmann M
    Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):434-450. PubMed ID: 30444745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of rifaximin on the hospital burden and infections in patients with hepatic encephalopathy: a retrospective observational study.
    De Graeve J; Vanderstraeten E; Delvaeye T; De Lepeleere S; De Somer T; Van Steenkiste C
    Acta Gastroenterol Belg; 2022; 85(3):433-437. PubMed ID: 35833904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy.
    Leevy CB; Phillips JA
    Dig Dis Sci; 2007 Mar; 52(3):737-41. PubMed ID: 17245628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic Encephalopathy Challenges, Burden, and Diagnostic and Therapeutic Approach.
    Yanny B; Winters A; Boutros S; Saab S
    Clin Liver Dis; 2019 Nov; 23(4):607-623. PubMed ID: 31563214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hepatic encephalopathy in the hospital.
    Leise MD; Poterucha JJ; Kamath PS; Kim WR
    Mayo Clin Proc; 2014 Feb; 89(2):241-53. PubMed ID: 24411831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.